Germline RET Leu56Met Variant Is Likely Not Causative of Multiple Endocrine Neoplasia Type 2

Overview of attention for article published in Frontiers in endocrinology, December 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 3 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 4,814 followers.

Germline RET Leu56Met Variant Is Likely Not Causative of Multiple Endocrine Neoplasia Type 2 https://t.co/nIY3ZSwRSe

20 Dec 2021

Reply Repost Favourite

New Research: Germline RET Leu56Met Variant Is Likely Not Causative of Multiple Endocrine Neoplasia Type 2: Activating variants in the receptor tyrosine kinase REarranged during Transfection (RET) cause multiple endocrine neoplasia… https://t.co/IUgqPHoHvF

01 Dec 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.